Decellularized heart extracellular matrix alleviates activation of hiPSC-derived cardiac fibroblasts
Source abstract
Abstract
Human induced pluripotent stem cell derived cardiac fibroblasts (hiPSC-CFs) play a critical role in modeling human cardiovascular diseases in vitro. However, current culture substrates used for hiPSC-CF differentiation and expansion, such as Matrigel and tissue culture plastic (TCPs), are tissue mismatched and may provide pathogenic cues. Here, we report that hiPSC-CFs differentiated on Matrigel and expanded on tissue culture plastic (M-TCP-iCFs) exhibit transcriptomic hallmarks of activated fibroblasts limiting their translational potential. To alleviate pathogenic activation of hiPSC-CFs, we utilized decellularized extracellular matrix derived from porcine heart extracellular matrix (HEM) to provide a biomimetic substrate for improving hiPSC-CF phenotypes. We show that hiPSC-CFs differentiated and expanded on HEM (HEM-iCFs) exhibited reduced expression of hallmark activated fibroblast markers versus M-TCP-iCFs while retaining their cardiac fibroblast phenotype. HEM-iCFs also maintained a reduction in expression of hallmark genes associated with pathogenic fibroblasts when seeded onto TCPs. Further, HEM-iCFs more homogenously integrated into an hiPSC-derived cardiac organoid model, resulting in improved cardiomyocyte sarcomere development. In conclusion, HEM provides an improved substrate for the differentiation and propagation of hiPSC-CFs for disease modeling.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Congenital heart defects research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (76)
Show source-provided references
1. The Global Burden of Cardiovascular Diseases and Risk10.1016/j.jacc.2022.11.005 ↗
2. Myocardial fibrosis as a pathway of prediction of ventricular arrhythmias and sudden cardiac death in patients with nonischemic dilated cardiomyopathy10.1097/HPC.0000000000000171 ↗
3. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis10.1016/j.jacc.2011.03.064 ↗
4. Myocardial fibrosis as a predictor of sudden death in patients with coronary artery disease10.1016/j.jacc.2020.10.046 ↗
5. Extracellular matrix and heart development10.1002/bdra.20810 ↗
6. Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration10.1007/s00441-016-2431-9 ↗
7. Cardiac fibrosis: the fibroblast awakens10.1161/CIRCRESAHA.115.306565 ↗
8. Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture10.15252/emmm.201506151 ↗
9. Multiscale analysis of extracellular matrix remodeling in the failing heart10.1161/CIRCRESAHA.120.317685 ↗
10. Clinical trial in a dish: personalized stem cell–derived cardiomyocyte assay compared with clinical trial results for two QT-prolonging drugs10.1111/cts.12674 ↗
11. Isogenic sets of hiPSC-CMs harboring distinct KCNH2 mutations differ functionally and in susceptibility to drug-induced arrhythmias10.1016/j.stemcr.2020.10.005 ↗
12. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity10.1038/nm.4087 ↗
13. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy10.1126/scitranslmed.3003552 ↗
14. Characterization and validation of a human 3D cardiac microtissue for the assessment of changes in cardiac pathology10.1038/s41598-018-28393-y ↗
15. Multi-cellularity in cardiac tissue engineering, how close are we to native heart tissue?10.1007/s10974-019-09528-8 ↗
16. Cardiac spheroids as promising in vitro models to study the human heart microenvironment10.1038/s41598-017-06385-8 ↗
17. Matrigel: basement membrane matrix with biological activity10.1016/j.semcancer.2005.05.004 ↗
18. Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts10.1002/dvdy.22280 ↗
19. Decellularized extracellular matrix materials for cardiac repair and regeneration10.1002/adhm.201801217 ↗
20. A bioprinted cardiac patch composed of cardiac-specific extracellular matrix and progenitor cells for heart repair10.1002/adhm.201800672 ↗
21. Methods of tissue decellularization used for preparation of biologic scaffolds and in vivo relevance10.1016/j.ymeth.2015.03.005 ↗
22. Preliminary experience with cardiac reconstruction using decellularized porcine extracellular matrix scaffold: human applications in congenital heart disease10.1177/2150135110362092 ↗
23. Controlling stem cell behavior with decellularized extracellular matrix scaffolds10.1016/j.cossms.2016.02.001 ↗
24. Heart extracellular matrix supports cardiomyocyte differentiation of mouse embryonic stem cells10.1016/j.jbiosc.2012.10.004 ↗
25. Extracellular matrix from embryonic myocardium elicits an early morphogenetic event in cardiac endothelial differentiation10.1016/0012-1606(87)90237-5 ↗
26. Developmental lineage of human pluripotent stem cell-derived cardiac fibroblasts affects their functional phenotype10.1096/fj.202100523R ↗
27. Long-term self-renewing human epicardial cells generated from pluripotent stem cells under defined xeno-free conditions10.1038/s41551-016-0003 ↗
28. ComBat-seq: batch effect adjustment for RNA-seq count data
29. Bioconductor: open software development for computational biology and bioinformatics10.1186/gb-2004-5-10-r80 ↗
30. Orchestrating high-throughput genomic analysis with Bioconductor10.1038/nmeth.3252 ↗
31. Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity10.1038/s41551-020-0539-4 ↗
32. Multicellular Human Cardiac Organoids Transcriptomically Model Distinct Tissue-Level Features of Adult Myocardium10.3390/ijms22168482 ↗
33. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq210.1186/s13059-014-0550-8 ↗
34. ggplot2: elegant graphics for data analysis10.1111/j.1467-985X.2010.00676_9.x ↗
35. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes10.1038/ng1180 ↗
36. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles10.1073/pnas.0506580102 ↗
37. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets10.1038/s41467-019-09234-6 ↗
38. Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy10.1038/s41586-022-04817-8 ↗
39. Three-dimensional heart extracellular matrix enhances chemically induced direct cardiac reprogramming10.1126/sciadv.abn5768 ↗
40. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions10.1038/nprot.2012.150 ↗
41. Directed differentiation and long-term maintenance of epicardial cells derived from human pluripotent stem cells under fully defined conditions10.1038/nprot.2017.080 ↗
42. Nanowires and Electrical Stimulation Synergistically Improve Functions of hiPSC Cardiac Spheroids10.1021/acs.nanolett.6b02093 ↗
43. Cell number per spheroid and electrical conductivity of nanowires influence the function of silicon nanowired human cardiac spheroids10.1016/j.actbio.2017.01.029 ↗
44. Silicon nanowire-induced maturation of cardiomyocytes derived from human induced pluripotent stem cells10.1021/nl502227a ↗
45. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes10.1016/j.stem.2012.09.013 ↗
46. Massive expansion and cryopreservation of functional human induced pluripotent stem cell-derived cardiomyocytes
47. Wnt activation and reduced cell-cell contact synergistically induce massive expansion of functional human iPSC-derived cardiomyocytes10.1016/j.stem.2020.06.001 ↗
48. iPSC-derived endothelial cell response to hypoxia via SDF1a/CXCR4 axis facilitates incorporation to revascularize ischemic retina10.1172/jci.insight.131828 ↗
49. Differential HDAC6 activity modulates ciliogenesis and subsequent mechanosensing of endothelial cells derived from pluripotent stem cells10.1016/j.celrep.2018.06.083 ↗
50. Directed Endothelial Progenitor Differentiation from Human Pluripotent Stem Cells Via Wnt Activation Under Defined Conditions10.1007/978-1-4939-6393-5_17 ↗
51. Inspiration from heart development: Biomimetic development of functional human cardiac organoids10.1016/j.biomaterials.2017.07.021 ↗
52. Targeting HIF‐α for robust prevascularization of human cardiac organoids
53. Human cardiac organoids to model COVID-19 cytokine storm induced cardiac injuries10.1002/term.3327 ↗
54. Functional cardiac fibroblasts derived from human pluripotent stem cells via second heart field progenitors10.1038/s41467-019-09831-5 ↗
55. Improved epicardial cardiac fibroblast generation from iPSCs10.1016/j.yjmcc.2021.11.011 ↗
56. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 201710.1016/S0140-6736(18)32203-7 ↗
57. Control of integrin expression by extracellular matrix10.1074/jbc.270.45.26794 ↗
58. Regulation of the expression of c-Myc by beta1 integrins in epithelial cells10.1038/sj.onc.1204152 ↗
59. Integrins and cadherins as therapeutic targets in fibrosis10.3389/fphar.2014.00131 ↗
60. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling10.1016/j.cardiores.2006.10.002 ↗
61. New insights into TGF-beta/Smad signaling in tissue fibrosis10.1016/j.cbi.2018.07.008 ↗
62. Fibroblast-specific TGF-beta-Smad2/3 signaling underlies cardiac fibrosis10.1172/JCI94753 ↗
63. Current understanding of the pathophysiology of myocardial fibrosis and its quantitative assessment in heart failure10.3389/fphys.2017.00238 ↗
64. The function of SPARC as a mediator of fibrosis10.2174/1874312901206010146 ↗
65. Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor beta1 in cultured normal human fibroblasts10.1002/art.20785 ↗
66. Fibronectin mediates activation of stromal fibroblasts by SPARC in endometrial cancer cells10.1186/s12885-021-07875-9 ↗
67. Cardiac fibroblasts: from origin to injury10.1016/j.cophys.2017.08.002 ↗
68. Origins of cardiac fibroblasts10.1161/CIRCRESAHA.110.231910 ↗
69. Generation of Quiescent Cardiac Fibroblasts From Human Induced Pluripotent Stem Cells for In Vitro Modeling of Cardiac Fibrosis10.1161/CIRCRESAHA.119.315491 ↗
70. Mechanical regulation of cardiac fibroblast profibrotic phenotypes10.1091/mbc.e17-01-0014 ↗
71. Maintaining resting cardiac fibroblasts in vitro by disrupting mechanotransduction10.1371/journal.pone.0241390 ↗
72. An improved method of maintaining primary murine cardiac fibroblasts in two-dimensional cell culture10.1038/s41598-019-49285-9 ↗
73. Fibroblasts and myofibroblasts: what are we talking about?10.1097/FJC.0b013e3182116e39 ↗
74. Human-iPSC-Derived cardiac stromal cells enhance maturation in 3D cardiac microtissues and reveal non-cardiomyocyte contributions to heart disease10.1016/j.stem.2020.05.004 ↗
75. Complex relationship between cardiac fibroblasts and cardiomyocytes in health and disease10.1161/JAHA.120.019338 ↗
76. Angiogenic properties of myofibroblasts isolated from normal human skin wounds10.1007/s10456-012-9253-5 ↗